AiCure

Parexel

NextDocs joins the Parexel Perceptive Partner Program

Monday, November 24, 2014 02:41 PM

NextDocs, a Conshohocken, Pa.-based provider of regulated content management and compliance solutions for the life sciences industry, has joined the Parexel Perceptive Partner Program. NextDocs will enhance and broaden its services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform, a suite of applications for managing clinical trials. 

More... »


Parexel opens new European coordination hub and distribution center

Friday, November 14, 2014 10:50 AM

Global CRO Parexel International has opened its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany.  

More... »


PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »

ProNAi Therapeutics adds five to senior management team

Thursday, October 23, 2014 03:17 PM

ProNAi Therapeutics, a private company dedicated to developing and commercializing a new class of therapies based on its proprietary DNAi platform, has added five seasoned executives to its senior management team.

More... »

CRF Health joins Perceptive Partner Program

Thursday, October 23, 2014 01:12 PM

CRF Health, a Plymouth Meeting, Pa.-based global provider of eCOA solutions for the life sciences industry, has joined the Parexel Perceptive Partner Program. As a member, CRF Health will expand the breadth and reach of its technology offering by providing standard integrations between the company's eCOA solutions and the Perceptive MyTrials eClinical platform. Customers will benefit from direct access to all their required technology and data through a single platform.

More... »

Parexel International acquires ClinIntel

Friday, October 3, 2014 10:58 AM

Global CRO Parexel International, headquartered in Waltham, Mass., has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in Crawley, U.K.

More... »

New ACRO survey: CRO members saw big growth in past decade

Friday, September 19, 2014 03:34 PM

The biopharmaceutical industry’s outsourcing strategy has enabled the eight members of the Association of Clinical Research Organizations (ACRO) to double in size over the past 10 years, today employing more than 100,000 professionals worldwide with a global payroll of nearly $6 billion.

More... »

Parexel expands Perceptive Partner Program, adds CRF Health and Clinical Ink

Monday, September 15, 2014 12:41 PM

Parexel International, a Massachusetts-based global biopharmaceutical services organization, has announced that clinical technology companies CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, and Clinical Ink, a Winston-Salem, N.C.-based eSource solutions company, have joined its Perceptive Partner Program. 

More... »

Parexel International acquires Atlas Medical Services

Monday, July 7, 2014 10:05 AM

Global CRO Parexel International has acquired Atlas Medical Services, a provider of clinical research services in Turkey, the Middle East and North Africa.

More... »

Parexel launches new version of Clinphone RTSM Services

Monday, June 23, 2014 03:45 PM

CRO Parexel International has launched a new version of its industry standard ClinPhone randomization and trial supply management (RTSM) services designed to help clients start clinical trials more quickly. The RTSM solution has been used in more than 3,000 studies involving over 400,000 sites and two million patients since 1993. Developed by Parexel Informatics, it is a key component of the Perceptive MyTrials platform, an integrated suite of applications for managing clinical trials.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs